<DOC>
	<DOCNO>NCT00425763</DOCNO>
	<brief_summary>We study clinical efficacy amodiaquine-artesunate currently study intermittent preventive therapy infant ( IPTi ) trial area order correlate preventive efficacy see IPTi efficacy treatment symptomatic malaria regimen .</brief_summary>
	<brief_title>Efficacy Amodiaquine-artesunate Children Aged 6-59 Months With Uncomplicated P. Falciparum Malaria</brief_title>
	<detailed_description>We propose conduct amodiaquine-artesunate efficacy trial Bondo District Hospital Kenya . The result enable u good interpret result main IPTi trial . We assess efficacy three day course amodiaquine plus three day artesunate ( AQ3/AS3 ) treatment symptomatic , uncomplicated P. falciparum infection . Study subject febrile child , 6-59 month old , laboratory-confirmed uncomplicated P. falciparum infection . Clinical parasitological parameter monitor 28-day follow-up period evaluate drug efficacy . Children follow closely sign drug failure recrudescence , child fail therapy treat Coartem , severe , quinine . We also perform drug resistance test parasite sample child treatment failure . The result efficacy trial allow u assist policymakers decide drug use IPTi , adopt national policy .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Amodiaquine</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<criteria>age 659 month axillary temperature ≥ 37.5º C , history fever previous 24 hour weight ≥ 5.0 kg slideconfirmed infection P. falciparum parasitemia 2000200,000 asexual form per μl ability willingness attend stipulate followup visit sign symptom severe disease weightforage ≤ 3rd percentile Kenya growth chart slide confirm infection Plasmodium spp. , besides falciparum severe anemia , define Hb &lt; 7 g/dl know hypersensitivity drug test enrolled IPTi trial know chronic disease</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>malaria</keyword>
	<keyword>efficacy</keyword>
	<keyword>intermittent preventive therapy infant</keyword>
	<keyword>drug resistance</keyword>
</DOC>